Emcure Pharmaceuticals Net Worth (Updated 2026).

Emcure Pharmaceuticals, a name now synonymous with quality and innovation in the pharmaceutical industry, had humble beginnings in the bustling city of Pune, India. Founded in 1983 by a visionary entrepreneur, Mr. Satish Mehta, the company started its journey as a small-scale formulation unit, focusing on manufacturing a limited range of generic drugs. The company’s inception was marked by a strong commitment to quality and affordability, a philosophy that would later become its hallmark.

The turning point for Emcure Pharmaceuticals came in the late 1990s when it decided to expand its horizons beyond the Indian market. The company began to explore opportunities in the global market, recognizing the potential for its high-quality, affordable products. This strategic shift was accompanied by significant investments in research and development, allowing Emcure to diversify its product portfolio and enter into complex therapeutic areas. The company’s commitment to innovation and quality, coupled with its competitive pricing strategy, began to attract attention from international markets, paving the way for its rise to fame in the global pharmaceutical industry.

Emcure Pharmaceuticals’ Current Net Worth (2025)

As of 2025, Emcure Pharmaceuticals’ current net worth stands at approximately $2.5 billion, according to the latest available information.

Career

Founded in 1983, Emcure Pharmaceuticals has grown to become one of India’s leading pharmaceutical companies. It started as a small-scale unit producing tablets and has since expanded into a global entity with a presence in over 70 countries.

Other Ventures

Emcure Pharmaceuticals has diversified its portfolio to include not just generic drugs, but also complex generics, biosimilars, and branded formulations. It has also ventured into contract manufacturing, providing services to global pharmaceutical companies.

Assets

Emcure Pharmaceuticals’ assets include six state-of-the-art manufacturing facilities in India, a research and development center, and a network of over 600 distributors worldwide. Its portfolio consists of over 1,000 products across various therapeutic areas.

Annual Income

In the fiscal year 2020-21, Emcure Pharmaceuticals reported an annual turnover of over $1.2 billion. This represents a significant increase from the previous year, demonstrating the company’s consistent growth and financial stability.

Frequently Asked Questions about  Emcure Pharmaceuticals

**Frequently Asked Questions: Emcure Pharmaceuticals**

1. What is Emcure Pharmaceuticals’ net worth?

Emcure Pharmaceuticals’ net worth is estimated to be around $2 billion.

2. When was Emcure Pharmaceuticals established?

Emcure Pharmaceuticals was established in 1981.

3. Who is the founder of Emcure Pharmaceuticals?

The founder of Emcure Pharmaceuticals is Satish Mehta.

4. Where is Emcure Pharmaceuticals headquartered?

Emcure Pharmaceuticals is headquartered in Pune, India.

5. What are some of the key products of Emcure Pharmaceuticals?

Some of the key products of Emcure Pharmaceuticals include Atorvastatin, Losartan, Ramipril, and several other generic drugs.

6. In which countries does Emcure Pharmaceuticals operate?

Emcure Pharmaceuticals operates in over 70 countries across the globe, including the US, Europe, and Asia.

7. What is the market capitalization of Emcure Pharmaceuticals?

The market capitalization of Emcure Pharmaceuticals is around $3 billion.

8. How many employees does Emcure Pharmaceuticals have?

Emcure Pharmaceuticals employs over 10,000 people worldwide.

9. What is the revenue of Emcure Pharmaceuticals?

The revenue of Emcure Pharmaceuticals is around $1 billion annually.

10. What is the stock symbol of Emcure Pharmaceuticals?

The stock symbol of Emcure Pharmaceuticals is EMCURE on the National Stock Exchange of India.